Dermatology Times has published a new case-based feature examining the assessment of a systemic-naive patient presenting with occupational plaque psoriasis. The piece, titled "Case 1: Assessing a Systemic-Naive Patient With Occupational Plaque Psoriasis," forms part of the outlet's continuing clinical case series aimed at grounding treatment decisions in real-world patient presentations.

The case centers on a patient who has not previously received systemic therapy for plaque psoriasis and whose disease exists alongside an occupational component — a factor that frequently complicates both disease severity assessment and treatment selection in routine dermatology practice. Systemic-naive status matters clinically because it forces the clinician to establish baseline disease burden, comorbidity profile, and candidacy for systemic agents without the confounding history of prior systemic exposure.

Occupational plaque psoriasis presents a distinct set of considerations for the treating dermatologist. Work-related triggers and exposures can sustain disease activity, and any treatment plan that ignores the workplace dimension risks underperforming. The case format used by Dermatology Times invites readers to weigh these variables — disease extent, functional impact, and the practical feasibility of therapies within a patient's working life — before committing to a systemic regimen.

For clinicians managing plaque psoriasis, the systemic-naive population represents a critical decision point. International treatment paradigms generally reserve systemic therapy, including biologics and oral small molecules, for patients with moderate-to-severe disease or with psoriasis significantly affecting quality of life and function. Establishing where a given patient sits on that spectrum — through validated severity measures and documented impairment — is the necessary first step the case is designed to rehearse.

The occupational angle adds a layer that pure severity scoring can miss. Patients whose work involves manual labor, chemical exposure, or skin friction may face both aggravated disease and practical barriers to certain therapies. A case-based discussion of such a patient lets dermatologists practice integrating severity assessment with real-world constraints, a skill increasingly emphasized as treatment options expand.

The full case is available through Dermatology Times. As case-based education continues to anchor psoriasis training, expect this series to serve as a template for how clinicians can structure first-line systemic decision-making in patients whose disease is entangled with their working environment.